Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

18

Full text

17

Free full text

7

Publication Types

Journal Article

19

Research Support, Non-U.S. Gov't

12

Review

7

Comparative Study

3

Randomized Controlled Trial

3

Clinical Trial

2

Research Support, U.S. Gov't, P.H.S.

1

Clinical Trial, Phase I

1

Observational Study

1

Research Support, N.I.H., Extramural

1

Publication Year

From

To

Quick links

Individual year

2018

2

2016

1

2015

2

2013

2

2012

2

2011

1

2010

1

2008

1

2007

1

2004

1

2002

2

2001

3

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Receptors, Thrombin""[mesh_terms]

19 Results

Searching titles within these results

Intracellular calcium release from human platelets: different messengers for multiple stores.

Isaac Jardín, José J López, José A Pariente, Ginés M Salido, Juan A Rosado

Trends in cardiovascular medicine 2008;18(2):57-61

International Union of Pharmacology. XXVIII. Proteinase-activated receptors.

Morley D Hollenberg, Steven J Compton

Pharmacological reviews 2002;54(2):203-17

Thrombin receptor antagonists; recent advances in PAR-1 antagonist development.

M Anderluh, M Sollner Dolenc

Current medicinal chemistry 2002;9(13):1229-50

Protease activated receptors: theme and variations.

P J O'Brien, L F Brass, M Kahn, M Molino

Oncogene 2001;20(13):1570-81

A cluster of aspartic residues in the extracellular loop II of PAR 4 is important for thrombin interaction and activation of platelets.

Daniel Sánchez Centellas, Sushanth Gudlur, Alejandro Vicente-Carrillo, Sofia Ramström, Tomas L Lindahl

Thrombosis research 2018;154():84-92

Differential effects of quercetin, apigenin and genistein on signalling pathways of protease-activated receptors PAR(1) and PAR(4) in platelets.

L Navarro-Núñez, J Rivera, J A Guerrero, C Martínez, V Vicente, M L Lozano

British journal of pharmacology 2010;158(6):1548-56

Anti-platelet effects of vitamin supplements in age-related macular degeneration: an in vitro study.

Marilita M Moschos, Konstantinos Laios, Sofia Androudi, Dimitrios S Ladas, Irini P Chatziralli

Cutaneous and ocular toxicology 2018;37(3):207-209

TRAP-induced platelet aggregation is enhanced in cardiovascular patients receiving dabigatran.

Christoph B Olivier, Patrick Weik, Melanie Meyer, Susanne Weber, Nathaly Anto-Michel, Philipp Diehl, Qian Zhou, Ulrich Geisen, Christoph Bode, Martin Moser

Thrombosis research 2016;138():63-68

Effects of the glycoprotein IIb/IIIa antagonist Roxifiban on P-selectin expression, fibrinogen binding, and microaggregate formation in a phase I dose-finding study: no evidence for platelet activation during treatment with a glycoprotein IIb/IIIa antagonist.

Dietmar Seiffert, Beth E Thomas, Jodi D Bradley, Deborah A Munzer, Maureen A Tchinnes, David M Kornhauser, Valerie A Cain, Tsuhung A Hua, Giora Z Feuerstein, David E Martin, Andrew M Stern

Platelets 2004;14(3):179-87

Flavan-3-ol-enriched dark chocolate and white chocolate improve acute measures of platelet function in a gender-specific way--a randomized-controlled human intervention trial.

Luisa M Ostertag, Paul A Kroon, Sharon Wood, Graham W Horgan, Elena Cienfuegos-Jovellanos, Shikha Saha, Garry G Duthie, Baukje de Roos

Molecular nutrition & food research 2013;57(2):191-202

Boron in drug discovery: carboranes as unique pharmacophores in biologically active compounds.

Michael Kassiou, Fatiah Issa, Louis M Rendina

Chemical reviews 2012;111(9):5701-22

Thrombin-induced platelet activation via PAR4: pivotal role for exosite II.

N Boknäs, L Faxälv, D Sanchez Centellas, M Wallstedt, S Ramström, M Grenegård, T L Lindahl

Thrombosis and haemostasis 2015;112(3):558-65

The roles and mechanisms of PAR4 and P2Y12/phosphatidylinositol 3-kinase pathway in maintaining thrombin-induced platelet aggregation.

Chin-Chung Wu, Shih-Yun Wu, Che-Ming Teng, Yang-Chang Wu, Sheng-Chu Kuo, Chieh-Yu Liao

British journal of pharmacology 2011;161(3):643-58

Pharmacodynamics and pharmacokinetics of eptifibatide in patients with acute coronary syndromes: prospective analysis from PURSUIT.

B E Tardiff, L K Jennings, R A Harrington, D Gretler, R F Potthoff, D A Vorchheimer, P R Eisenberg, A M Lincoff, M Labinaz, D M Joseph, M F McDougal, N S Kleiman

Circulation 2001;104(4):399-405

Novel mechanisms for activated protein C cytoprotective activities involving noncanonical activation of protease-activated receptor 3.

Laurent O Mosnier, Laurent Burnier

Blood 2013;122(5):807-16

Results: 1 – 15 / 19

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.